The FDA will require GSK and Pfizer to include on the label of their respiratory syncytial virus (RSV) vaccines a warning ...

GSK (GSK) is in advanced discussions to purchase privately-owned U.S. biotech IDRx, which is working on a treatment for rare gastrointestinal ...

We swear, kids, it has nothing to do with whether you were naughty or nice. Canada Post announced today that Santa will not be writing back to the children who write him letters this year.

GSK has acquired exclusive global rights to progress the clinical development and commercialisation of GSK’227. Credit: MAXSHOT.PL/Shutterstock. GlaxoSmithKline (GSK)’s B7-H3-targeted antibody-drug ...

In her insightful column (“How to trade in the Trump era”, Opinion, FT Weekend, November 16) Gillian Tett depicts seven points that investors need to ponder if they want to continue to ...

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order ...

Continuing on with list season, we’re pivoting our focus to the best cover songs of the year. We opted to limit the ranking to one entry per project, as something like Thanks to I Saw the TV ...

Speaking to The Pharma Letter about the collaboration, Relation chief executive David Roblin (pictured, above, far right) explained: “We picked GSK because they understand our desires and have a ...

The United States Postal Service and volunteers have responded to North Pole holiday correspondence over the past century Alicia Ault; Updated by Kayla Randall The mailbox for letters to Santa ...

Archaeologists uncovered a basalt tablet in the Bashplemi Lake region of Georgia with an unknown language carved into its face. The tablet featured 60 characters across seven rows. Experts said ...

As he stood with arms around a flag and pole, he gestured a kiss for a second and I caught it on film. He squeezed the fabric and said, “We are gonna fix it.” Contact us at letters@time.com ...

GSK plc's stock downgraded from “Buy” to “Hold” due to litigation risks, disappointing RSV vaccine sales, and competitive pressures in the HIV space. Despite strong cash flow, GSK's Zantac ...